Write your message

XML Persian Abstract Print


1- , s.faraj.b@iau.ac.ir
Abstract:   (154 Views)
Background: Non‐alcoholic fatty liver disease (NAFLD) is associated with increased production/deposition of collagen and extracellular matrix. The aim of this study is to investigate the effect of aerobic exercise and resveratrol on the expression of Fibrillin-1 and Asprosin in adipose tissue of NAFLD rats.
Materials and Methods: In this experimental study, Thirty five Wistar male rats were classified into two groups NAFLD (n=28) and Control-Normal (n=7). NAFLD was induced in rats with high fat diet and then subdivided into 4 subgroups NAFLD, TRNAF, SUPNAF and TRSUPNAF. Training groups have performed a running program on a motor-driven treadmill for eight weeks. Resveratrol (20 mg/kg) was injected into the SUPNAF and TRSUPNAF groups. Forty-eight hours after the last training session, rats were anesthetized; hearts were excised and immediately frozen in liquid nitrogen and stored at -80°C for measuring the indexes. Statistical analysis was performed using a one-way analysis of variance, and significance was accepted at p ≤ 0.05.
Results Induction of NAFLD was associated with increased expression of Fibrillin-1 and Asprosin. Significant reductions of these genes in NAFLDT (p= 0.037, p= 0.047, respectively) and NAFLDTRSV (p= 0.0001; both) groups compared to the NAFLD. Furthermore, the NAFLDTRSV showed significantly lower expression compared to the NAFLDT (p = 0.037, p = 0.047) and NAFLDRSV (p = 0.007, p = 0.026) (p ≤ 0.05).
Conclusion: Exercise training along with resveratrol could improve adipose tissue disorders caused by NAFLD by significantly reducing the expression of fibrillin-1 and asprosin. However, the effect of resveratrol alone is not effective and more research is needed.
 
     
Type of Study: Research | Subject: Physiology

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Complementary Medicine Journal

Designed & Developed by : Yektaweb